Skip to main content
VCbacked
Log inGet Started

Progentos Therapeutics

Watertown, United States

Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.

$65.0M raised
May 2024
Series A
Life ScienceMedicalTherapeutics

Top Investors

Longwood FundMission BioCapitalForbion Capital PartnersAlta PartnersDolby Family Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Progentos Therapeutics

How much funding has Progentos Therapeutics raised?
Progentos Therapeutics has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
Who are Progentos Therapeutics's investors?
Progentos Therapeutics's investors include Longwood Fund, Mission BioCapital, Forbion Capital Partners, Alta Partners, Dolby Family Ventures.
Where is Progentos Therapeutics headquartered?
Progentos Therapeutics is headquartered in Watertown, United States.
What does Progentos Therapeutics do?
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
What stage is Progentos Therapeutics at?
Progentos Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Progentos Therapeutics — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/progentos-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2024). Progentos Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/progentos-therapeutics
Wikipedia (cite web)
{{cite web |title=Progentos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/progentos-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Life Science

View all
Pharvaris
Zug
Sedivention
Munich$848K
Modicus Prime
Austin
Kanvas Biosciences
Monmouth Junction$12.5M
Dandelion Health AI
New York$15.9M
Quiver Bioscience
Cambridge